financetom
SIGA
financetom
/
Healthcare
/
SIGA
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
SIGA Technologies, Inc.SIGA
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States.

Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus.

The company was incorporated in 1995 and is headquartered in New York, New York.

Latest News >
A2Z Smart Technologies Scraps Planned Public Offering; To Raise Capital in Direct Offering, Private Placement
A2Z Smart Technologies Scraps Planned Public Offering; To Raise Capital in Direct Offering, Private Placement
Apr 2, 2024
04:14 AM EDT, 04/02/2024 (MT Newswires) -- A2Z Smart Technologies Corp. ( AZ ) said late Monday it has withdrawn its previously announced public offering with ThinkEquity as its placement agent. The company said it now plans to raise up to $4.5 million in a registered direct offering of common shares, and up to $2.5 million in a private placement...
Investor Sentiment Improves, But Dow Falls Over 200 Points
Investor Sentiment Improves, But Dow Falls Over 200 Points
Apr 2, 2024
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the Greed zone on Monday. U.S. stocks closed mostly lower on Monday, with the Dow Jones index closing lower by more than 200 points during the session. The headline annual inflation rate, as measured by personal consumption expenditures (PCE), rose...
Hutchmed, Innovent Biologics Say Chinese Regulator Accepts Application for Endometrial Cancer Drug Combination
Hutchmed, Innovent Biologics Say Chinese Regulator Accepts Application for Endometrial Cancer Drug Combination
Apr 2, 2024
04:10 AM EDT, 04/02/2024 (MT Newswires) -- Hutchmed ( HCM ) and Innovent Biologics said Tuesday a new drug application for the sintilimab-fruquintinib combination for the treatment of advanced endometrial cancer has been accepted by the China National Medical Products Administration with a priority review status. The filing was supported by data from a phase 2 trial which evaluated the...
Ashford Board Approves Plan to Terminate Stock Registration Targeting $2.5 Million of Savings Annually
Ashford Board Approves Plan to Terminate Stock Registration Targeting $2.5 Million of Savings Annually
Apr 2, 2024
04:26 AM EDT, 04/02/2024 (MT Newswires) -- Ashford (AINC) said late Monday that a special committee of independent and disinterested directors recommended, and its board approved, a plan to terminate the company's common-stock registration and to delist its shares from the NYSE American. The company expects the plan to be initiated in the summer, subject to approvals. Ashford is taking...
Copyright 2023-2026 - www.financetom.com All Rights Reserved